Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2012 (2012), Article ID 178675, 5 pages
http://dx.doi.org/10.1155/2012/178675
Review Article

The Emerging Epidemic of Obesity, Diabetes, and the Metabolic Syndrome in China

1Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30322, USA
2Department of Epidemiology and Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
3Center for Heart Disease Prevention, Emory University School of Medicine, 1365 Clifton Road, NE Building A, Suite 2200, Atlanta, GA 30322, USA

Received 24 June 2011; Accepted 27 July 2011

Academic Editor: Martin Thoenes

Copyright © 2012 Jia Shen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The World Bank, Development Indicators 2011, World Bank, Washington, DC, USA, 2011.
  2. S. Leeder, S. Raymond, and H. Greenberg, A Race Against Time: The Challenge of Cardiovascular Disease in Developing Countries, Trustees of Columbia University, New York, NY, USA, 2004.
  3. Ministry of Health, People’s Republic of China, “China’s Smoking & Health Report,” Tech. Rep., Ministry of Health, Beijing, China, 2006. View at Google Scholar
  4. H. Tian, H. Xie, G. Song, H. Zhang, and G. Hu, “Prevalence of overweight and obesity among 2.6million rural Chinese adults,” Preventive Medicine, vol. 48, no. 1, pp. 59–63, 2009. View at Publisher · View at Google Scholar · View at PubMed
  5. Y. Wang, J. Mi, X. Y. Shan, Q. J. Wang, and K. Y. Ge, “Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China,” International Journal of Obesity, vol. 31, no. 1, pp. 177–188, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. D. Hu, P. Fu, J. Xie et al., “Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study,” Diabetes Research and Clinical Practice, vol. 81, no. 2, pp. 250–257, 2008. View at Publisher · View at Google Scholar · View at PubMed
  7. World Health Organization Department of Non-Communicable Disease Surveillance, “Definition, diagnosis and classification of diabetes mellitus and its complications,” Tech. Rep. 99.2, WHO, Geneva, Switzerland, 1999. View at Google Scholar
  8. World Health Organization, “Preventing and managing the Global Epidemic—report of a WHO Consultation,” WHO Technical Report Series 894, WHO, Geneva, Switzerland, 2000. View at Google Scholar
  9. J. I. Cleeman, “Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar
  10. C. Barba, T. Cavalli-Sforza, J. Cutter et al., “Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies,” Lancet, vol. 363, no. 9403, pp. 157–163, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. NCEP ATP III 2002.
  12. WHO 1999.
  13. WHO 2000.
  14. The World Health Organization, “Physical status: the use and interpretation of anthropometry—report of a WHO expert committee,” WHO Technical Report 854, World Health Organization, Geneva, Switzerland, 1995. View at Google Scholar
  15. S. M. Grundy, D. Becker, L. T. Clark et al., “Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report,” Circulation, vol. 106, no. 25, pp. 3143–3421, 2002. View at Google Scholar
  16. B. F. Zhou, “Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults,” Biomedical and Environmental Sciences, vol. 15, no. 1, pp. 83–96, 2002. View at Google Scholar
  17. A. Misra, “Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups,” International Journal of Obesity, vol. 27, no. 11, pp. 1294–1296, 2003. View at Publisher · View at Google Scholar · View at PubMed
  18. S. Inoue, P. Zimmet, I. Caterson et al., The Asia-Pacific Perspective: Redefining Obesity and its Treatment, Health Communications Australia Pty Limited on behalf of the Steering Committee, 2000.
  19. G. N. Thomas, S. Y. Ho, K. S. L. Lam, E. D. Janus, A. J. Hedley, and H. L. Tai, “Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese,” Obesity Research, vol. 12, no. 11, pp. 1805–1813, 2004. View at Google Scholar
  20. C. Chen and F. C. Lu, “The guidelines for prevention and control of overweight and obesity in Chinese adults,” Biomedical and Environmental Sciences, vol. 176, pp. 1–35, 2006. View at Google Scholar
  21. A. C. Bell, K. Ge, and B. M. Popkin, “The road to obesity or the path to prevention: motorized transportation and obesity in China,” Obesity Research, vol. 10, no. 4, pp. 277–283, 2002. View at Google Scholar
  22. H. Wang, S. Du, F. Zhai, and B. M. Popkin, “Trends in the distribution of body mass index among Chinese adults, aged 20-45 years (1989-2000),” International Journal of Obesity, vol. 31, no. 2, pp. 272–278, 2007. View at Publisher · View at Google Scholar · View at PubMed
  23. W. P. Jia, C. Wang, S. Jiang, and J. M. Pan, “Characteristics of obesity and its related disorders in china,” Biomedical and Environmental Sciences, vol. 23, no. 1, pp. 4–11, 2010. View at Publisher · View at Google Scholar
  24. W. Zhao, Y. Zhai, J. Hu et al., “Economic burden of obesity-related chronic diseases in Mainland China,” Obesity Reviews, vol. 9, no. 1, pp. 62–67, 2008. View at Publisher · View at Google Scholar · View at PubMed
  25. X. Pan, W. Yang, and J. Liu, “Prevalence of diabetes and its risk factors in China 1994. National Diabetes Prevention and Control Cooperative Group,” Diabetes Care, vol. 20, pp. 1664–1669, 1994. View at Google Scholar
  26. D. Gu, K. Reynolds, X. Duan et al., “Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: international collaborative study of cardiovascular disease in asia (InterASIA),” Diabetologia, vol. 46, no. 9, pp. 1190–1198, 2003. View at Publisher · View at Google Scholar · View at PubMed
  27. W. Yang, J. Lu, J. Weng et al., “Prevalence of diabetes among men and women in China,” New England Journal of Medicine, vol. 362, no. 12, pp. 1090–1101, 2010. View at Publisher · View at Google Scholar · View at PubMed
  28. W. Wang, W. P. McGreevey, C. Fu et al., “Type 2 diabetes mellitus in China: a preventable economic burden,” American Journal of Managed Care, vol. 15, no. 9, pp. 593–601, 2009. View at Google Scholar
  29. B. Isomaa, P. Almgren, T. Tuomi et al., “Cardiovascular morbidity and mortality associated with the metabolic syndrome,” Diabetes Care, vol. 24, no. 4, pp. 683–689, 2001. View at Google Scholar
  30. J. Chen, P. Muntner, L. L. Hamm et al., “The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults,” Annals of Internal Medicine, vol. 140, no. 3, pp. 167–I39, 2004. View at Google Scholar
  31. Further Study of Risk Factors for Stroke and Coronary Heart Disease Cooperation Group, “The prevalence of metabolic syndrome in a 11 provinces cohort in China,” Zhonghua Yu Fang Yi Xue Za Zhi, vol. 36, pp. 298–300, 2002. View at Google Scholar
  32. D. Gu, A. Gupta, P. Muntner et al., “Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia),” Circulation, vol. 112, no. 5, pp. 658–665, 2005. View at Publisher · View at Google Scholar · View at PubMed
  33. C. E. Tan, S. Ma, D. Wai, S. K. Chew, and E. S. Tai, “Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to absians?” Diabetes Care, vol. 27, no. 5, pp. 1182–1186, 2004. View at Publisher · View at Google Scholar
  34. W. Y. Lee, J. S. Park, S. Y. Noh, E. J. Rhee, S. W. Kim, and P. Z. Zimmet, “Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects,” Diabetes Research and Clinical Practice, vol. 65, no. 2, pp. 143–149, 2004. View at Publisher · View at Google Scholar · View at PubMed
  35. B. Hildrum, A. Mykletun, T. Hole, K. Midthjell, and A. A. Dahl, “Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study,” BMC Public Health, vol. 7, article 220, 2007. View at Publisher · View at Google Scholar · View at PubMed
  36. A. T. Kraja, I. B. Borecki, K. North et al., “Longitudinal and age trends of metabolic syndrome and its risk factors: the family heart study,” Nutrition and Metabolism, vol. 3, article 41, 2006. View at Publisher · View at Google Scholar · View at PubMed
  37. E. S. Ford, W. H. Giles, and W. H. Dietz, “Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey,” Journal of the American Medical Association, vol. 287, no. 3, pp. 356–359, 2002. View at Google Scholar
  38. The United Nations Population Division, “World Population Ageing: 1950–2050,” Tech. Rep. 207, UN, New York, NY, USA, 2001. View at Google Scholar
  39. G. N. Thomas, S. Y. Ho, E. D. Janus, K. S. L. Lam, A. J. Hedley, and T. H. Lam, “The US national cholesterol education programme adult treatment panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population,” Diabetes Research and Clinical Practice, vol. 67, no. 3, pp. 251–257, 2005. View at Publisher · View at Google Scholar · View at PubMed
  40. R. B. Ervin, “Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States,” National health statistics reports, no. 13, pp. 1–7, 2009. View at Google Scholar
  41. S. M. Grundy, “Metabolic syndrome pandemic,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 4, pp. 629–636, 2008. View at Publisher · View at Google Scholar · View at PubMed
  42. S. Ebrahim, S. Kinra, L. Bowen et al., “The effect of rural-to-urban migration on obesity and diabetes in india: a cross-sectional study,” PLoS Medicine, vol. 7, no. 4, 2010. View at Publisher · View at Google Scholar · View at PubMed
  43. A. Moran, D. Gu, D. Zhao et al., “Future cardiovascular disease in China Markov model and risk factor scenario projections from the coronary heart disease Policy Model-China,” Circulation: Cardiovascular Quality and Outcomes, vol. 3, no. 3, pp. 243–252, 2010. View at Publisher · View at Google Scholar · View at PubMed
  44. G. H. Dong, Z. Q. Sun, X. Z. Zhang et al., “Prevalence, awareness, treatment & control of hypertension in rural Liaoning province,” China Indian Journal of Medical Research, vol. 128, no. 2, pp. 122–127, 2008. View at Google Scholar
  45. Ministry of Health, People’s Republic of China, “Report on the 1998 national health services survey results,” Tech. Rep., Ministry of Health, Beijing, China, 1999. View at Google Scholar
  46. S. Anand, V. Y. Fan, J. Zhang et al., “China's human resources for health: quantity, quality, and distribution,” Lancet, vol. 372, no. 9651, pp. 1774–1781, 2008. View at Publisher · View at Google Scholar · View at PubMed
  47. M. H. Cheng, “Asia-Pacific faces diabetes challenge,” Lancet, vol. 375, no. 9733, pp. 2207–2210, 2010. View at Publisher · View at Google Scholar